Release Date: 26/08/10 09:22 Summary: MUE Appendix 4E and Full Year Financial Report Price Sensitive: Yes Download Document 2.87MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%